Prisca Girotti

534 total citations
10 papers, 466 citations indexed

About

Prisca Girotti is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Prisca Girotti has authored 10 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 2 papers in Physiology. Recurrent topics in Prisca Girotti's work include Receptor Mechanisms and Signaling (8 papers), Neuropeptides and Animal Physiology (5 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Prisca Girotti is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Neuropeptides and Animal Physiology (5 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Prisca Girotti collaborates with scholars based in Italy, Sweden and Switzerland. Prisca Girotti's co-authors include S. Consolo, Rosalia Bertorelli, Ülo Langel, Tiit Land, Katarina Bedecs, Tamás Bartfai, Giovanni Russi, G. Di Chiara, Zsuzsanna Wiesenfeld‐Hallin and Xingtao Xu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Brain Research and Journal of Neurochemistry.

In The Last Decade

Prisca Girotti

10 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prisca Girotti Italy 10 431 341 123 64 41 10 466
L.L. Iversen United States 11 461 1.1× 303 0.9× 53 0.4× 29 0.5× 123 3.0× 14 549
Osamu Murakami Japan 9 279 0.6× 244 0.7× 51 0.4× 27 0.4× 26 0.6× 9 362
Johan Runesson Sweden 11 298 0.7× 201 0.6× 66 0.5× 31 0.5× 58 1.4× 15 359
Deanne M. Dean Canada 8 408 0.9× 310 0.9× 59 0.5× 17 0.3× 126 3.1× 8 539
S.D. Iversen United States 8 380 0.9× 197 0.6× 56 0.5× 15 0.2× 113 2.8× 11 472
Claudia Bouvier United States 7 618 1.4× 537 1.6× 63 0.5× 121 1.9× 214 5.2× 8 736
Ch. Heym Germany 11 307 0.7× 163 0.5× 79 0.6× 23 0.4× 110 2.7× 23 356
Norio Matsushita Japan 12 335 0.8× 128 0.4× 72 0.6× 154 2.4× 40 1.0× 24 557
Hiroyuki Nogi Japan 9 378 0.9× 238 0.7× 56 0.5× 130 2.0× 30 0.7× 11 417
J.‐X. Hao Sweden 9 287 0.7× 177 0.5× 59 0.5× 34 0.5× 274 6.7× 11 369

Countries citing papers authored by Prisca Girotti

Since Specialization
Citations

This map shows the geographic impact of Prisca Girotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prisca Girotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prisca Girotti more than expected).

Fields of papers citing papers by Prisca Girotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prisca Girotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prisca Girotti. The network helps show where Prisca Girotti may publish in the future.

Co-authorship network of co-authors of Prisca Girotti

This figure shows the co-authorship network connecting the top 25 collaborators of Prisca Girotti. A scholar is included among the top collaborators of Prisca Girotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prisca Girotti. Prisca Girotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Radaelli, Giuseppe, et al.. (1994). Evaluation of the tumor-promoting activity of two β-adrenoreceptor blocking agents, propranolol and atenolol, in liver of Fischer 344 rats. Carcinogenesis. 15(11). 2531–2539. 14 indexed citations
2.
Girotti, Prisca, Rosalia Bertorelli, Gilberto Fisone, et al.. (1993). N-terminal galanin fragments inhibit the hippocampal release of acetylcholine in vivo. Brain Research. 612(1-2). 258–262. 28 indexed citations
3.
Consolo, S., et al.. (1993). Chapter 24: D1 and D2 dopamine receptors and the regulation of striatal acetylcholine release in vivo. Progress in brain research. 98. 201–207. 21 indexed citations
4.
Bartfai, T., Ülo Langel, Katarina Bedecs, et al.. (1993). Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes.. Proceedings of the National Academy of Sciences. 90(23). 11287–11291. 119 indexed citations
5.
Russi, Giovanni, Prisca Girotti, Cristina Cadoni, G. Di Chiara, & S. Consolo. (1993). Neuroleptics increase striatal acetylcholine release by a sequential D-1 and D-2 receptor mechanism. Neuroreport. 4(12). 1335–1338. 11 indexed citations
6.
Consolo, S., Prisca Girotti, Giovanni Russi, & G. Di Chiara. (1992). Endogenous Dopamine Facilitates Striatalln Vivo Acetylcholine Release by Acting on D1 Receptors Localized in the Striatum. Journal of Neurochemistry. 59(4). 1555–1557. 68 indexed citations
7.
Girotti, Prisca, et al.. (1992). Mechanism of the galanin induced increase in acetylcholine release in vivo from striata of freely moving rats. Brain Research. 589(1). 33–38. 11 indexed citations
8.
Bertorelli, Rosalia, et al.. (1992). Effect of tianeptine on the central cholinergic system: involvement of serotonin. Naunyn-Schmiedeberg s Archives of Pharmacology. 345(3). 21 indexed citations
9.
10.
Bartfai, Tamás, Katarina Bedecs, Tiit Land, et al.. (1991). M-15: high-affinity chimeric peptide that blocks the neuronal actions of galanin in the hippocampus, locus coeruleus, and spinal cord.. Proceedings of the National Academy of Sciences. 88(23). 10961–10965. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026